BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35637963)

  • 21. Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin.
    Fumagalli M; Musso T; Vermi W; Scutera S; Daniele R; Alotto D; Cambieri I; Ostorero A; Gentili F; Caposio P; Zucca M; Sozzani S; Stella M; Castagnoli C
    Exp Dermatol; 2007 Jul; 16(7):600-10. PubMed ID: 17576240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arctigenin suppresses fibroblast activity and extracellular matrix deposition in hypertrophic scarring by reducing inflammation and oxidative stress.
    Jiang L; Deng Y; Li W; Lu Y
    Mol Med Rep; 2020 Dec; 22(6):4783-4791. PubMed ID: 33174021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Krüppel-like Factor-4-Mediated Macrophage Polarization and Phenotypic Transitions Drive Intestinal Fibrosis in THP-1 Monocyte Models In Vitro.
    Kanno T; Katano T; Shimura T; Tanaka M; Nishie H; Fukusada S; Ozeki K; Ogawa I; Iwao T; Matsunaga T; Kataoka H
    Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792896
    [No Abstract]   [Full Text] [Related]  

  • 24. miR-155 inhibits the formation of hypertrophic scar fibroblasts by targeting HIF-1α via PI3K/AKT pathway.
    Wu X; Li J; Yang X; Bai X; Shi J; Gao J; Li Y; Han S; Zhang Y; Han F; Liu Y; Li X; Wang K; Zhang J; Wang Z; Tao K; Hu D
    J Mol Histol; 2018 Aug; 49(4):377-387. PubMed ID: 29785488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of protease-activated receptor-1 and -2 in human scar formation.
    Materazzi S; Pellerito S; Di Serio C; Paglierani M; Naldini A; Ardinghi C; Carraro F; Geppetti P; Cirino G; Santucci M; Tarantini F; Massi D
    J Pathol; 2007 Aug; 212(4):440-9. PubMed ID: 17597495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-fibrotic actions of interleukin-10 against hypertrophic scarring by activation of PI3K/AKT and STAT3 signaling pathways in scar-forming fibroblasts.
    Shi J; Li J; Guan H; Cai W; Bai X; Fang X; Hu X; Wang Y; Wang H; Zheng Z; Su L; Hu D; Zhu X
    PLoS One; 2014; 9(5):e98228. PubMed ID: 24878845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smad7 down-regulation via ubiquitin degradation mediated by Smurf2 in fibroblasts of hypertrophic scars in burned patients.
    Zhang Z; Liu C; Chen B; Tang W; Liu Z; Cao W; Li X
    Burns; 2021 Sep; 47(6):1333-1341. PubMed ID: 33436154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombospondin-4 critically controls transforming growth factor β1 induced hypertrophic scar formation.
    Qian W; Li N; Cao Q; Fan J
    J Cell Physiol; 2018 Jan; 234(1):731-739. PubMed ID: 30132849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct roles of KLF4 in mesenchymal cell subtypes during lung fibrogenesis.
    Chandran RR; Xie Y; Gallardo-Vara E; Adams T; Garcia-Milian R; Kabir I; Sheikh AQ; Kaminski N; Martin KA; Herzog EL; Greif DM
    Nat Commun; 2021 Dec; 12(1):7179. PubMed ID: 34893592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA expression signature and the therapeutic effect of the microRNA‑21 antagomir in hypertrophic scarring.
    Guo L; Xu K; Yan H; Feng H; Wang T; Chai L; Xu G
    Mol Med Rep; 2017 Mar; 15(3):1211-1221. PubMed ID: 28075443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adipose tissue-derived stem cells inhibit hypertrophic scar (HS) fibrosis via p38/MAPK pathway.
    Chai CY; Song J; Tan Z; Tai IC; Zhang C; Sun S
    J Cell Biochem; 2019 Mar; 120(3):4057-4064. PubMed ID: 30260015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-145-5p attenuates hypertrophic scar via reducing Smad2/Smad3 expression.
    Shen W; Wang Y; Wang D; Zhou H; Zhang H; Li L
    Biochem Biophys Res Commun; 2020 Jan; 521(4):1042-1048. PubMed ID: 31732152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Botulinum Toxin Type A on Differentiation of Fibroblasts Derived from Scar Tissue.
    Jeong HS; Lee BH; Sung HM; Park SY; Ahn DK; Jung MS; Suh IS
    Plast Reconstr Surg; 2015 Aug; 136(2):171e-178e. PubMed ID: 26218391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrantly expressed long noncoding RNAs in hypertrophic scar fibroblasts in vitro: A microarray study.
    Tu L; Huang Q; Fu S; Liu D
    Int J Mol Med; 2018 Apr; 41(4):1917-1930. PubMed ID: 29393369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects and mechanism of age on the stiffness and the fibrotic phenotype of fibroblasts of human hypertrophic scar].
    Zhu DZ; Yao B; Cui XL; Huang S; Fu X
    Zhonghua Shao Shang Za Zhi; 2021 Oct; 37(10):937-945. PubMed ID: 34689463
    [No Abstract]   [Full Text] [Related]  

  • 36. Knockdown of FAM225B inhibits the progression of the hypertrophic scar following glaucoma surgery by inhibiting autophagy.
    Ma X; Liu L
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal HMGB1 Activates Dermal Fibroblasts and Causes Hypertrophic Scar Formation in Reduced Hydration.
    Zhao J; Yu J; Xu Y; Chen L; Zhou F; Zhai Q; Wu J; Shu B; Qi S
    J Invest Dermatol; 2018 Nov; 138(11):2322-2332. PubMed ID: 29787749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of basic fibroblast growth factor and its receptor by fibroblast, macrophages and mast cells in hypertrophic scar.
    Akimoto S; Ishikawa O; Iijima C; Miyachi Y
    Eur J Dermatol; 1999; 9(5):357-62. PubMed ID: 10417437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smad interacting protein 1 influences transforming growth factor-β
    Fang X; Hu X; Zheng Z; Tao K; Wang H; Guan H; Shi J; Ji P; Cai W; Bai X; Zhu X; Han J; Liu J; Hu D
    J Mol Histol; 2019 Dec; 50(6):503-514. PubMed ID: 31595443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of microRNA-296 in rabbit hypertrophic scars and its role to human fibroblasts].
    Guo BY; Lin F; Bai ZM; Tao K; Wang HY
    Zhonghua Shao Shang Za Zhi; 2021 Aug; 37(8):725-730. PubMed ID: 34404160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.